As proof-of-principle, the team designs a potent anti-cancer compound.
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.
“This is the first time therapeutic small molecules have been rationally designed from only an RNA sequence—something many doubted could be done,” said Matthew Disney, PhD, an associate professor at TSRI who led the study. “In this case, we have shown that that approach allows for specific and unprecedented targeting of an RNA that causes cancer.”
The technique, described in the journal Nature Chemical Biology online ahead of print on February 9, 2014, was dubbed Inforna.
“With our program, we can identify compounds with high specificity,” said Sai Pradeep Velagapudi, the first author of the study and a graduate student working in the Disney lab. “In the future, we hope we can design drug candidates for other cancers or for any pathological RNA.”
In Search of New Approaches
In their research program, Disney and his team has been developing approaches to understand the binding of drugs to RNA folds. In particular, the lab is interested in manipulating microRNAs.
Discovered only in the 1990s, microRNAs are short molecules that work within virtually all animal and plant cells. Typically each one functions as a “dimmer switch” for one or more genes; it binds to the transcripts of those genes and effectively keeps them from being translated into proteins. In this way microRNAs can regulate a wide variety of cellular processes.
Some microRNAs have been associated with diseases. MiR-96 microRNA, for example, is thought to promote cancer by discouraging a process called apoptosis or programmed cell death that can rid the body of cells that begin to grow out of control.
As part of its long-term program, the Disney lab developed computational approaches that can mine information against such genome sequences and all cellular RNAs with the goal of identifying drugs that target such disease-associated RNAs while leaving others unaffected.
“In recent years we’ve seen an explosion of information about the many roles of RNA in biology and medicine,” said Peter Preusch, PhD, of the National Institute of Health‘s National Institute of General Medical Sciences, which partially funded the research. “This new work is another example of how Dr. Disney is pioneering the use of small molecules to manipulate disease-causing RNAs, which have been underexplored as potential drug targets.”
‘Unprecedented’ Findings
In the new study, Disney and colleagues describe their computational technique, which identifies optimal drug targets by mining a database of drug-RNA sequence (“motif”) interactions against thousands of cellular RNA sequences.
Using Inforna, the team identified compounds that can target microRNA-96, as well as additional compounds that target nearly two dozen other disease-associated microRNAs.
The researchers showed that the drug candidate that inhibited microRNA-96 inhibited cancer cell growth. Importantly, they also showed that cells without functioning microRNA-96 were unaffected by the drug.
“This illustrates an unparalleled selectivity for the compound,” Disney noted. “In contrast, typical cancer therapeutics target cells indiscriminately, often leading to side effects that can make these drugs difficult for patients to tolerate.”
Disney added that the new drug candidate, which is easy to produce and cell permeable, targets microRNA-96 far more specifically than the state-of-the-art method to target RNA (using oligonucleotides) currently in use. “That’s unprecedented and provides great excitement for future developments.”
The Latest on: New medicines
[google_news title=”” keyword=”New medicines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: New medicines
- Obituaries PGe PG Store Archives Classifiedson May 1, 2024 at 8:07 am
A Lawrence County man was sentenced to 97 months in federal prison for drug trafficking and firearms offenses, the United States Attorney’s ...
- No need to fear menopause hormone drugs, finds major women’s health studyon May 1, 2024 at 7:59 am
The Women’s Health Initiative scared women and doctors away from menopause hormone therapy over 20 years ago. A follow-up found fears were largely overblown.
- Lilly sees quarterly profit jump 67% on demand for new weight-loss drugson May 1, 2024 at 7:49 am
Eli Lilly and Co. said Tuesday that “exceptionally strong demand” for diabetes drugs Mounjaro and weight-loss drug Zepbound helped push first quarter profit up 67%, but warned that it expects tight ...
- CT man on supervised release for drug conviction for overdoses sentenced for violating conditionson May 1, 2024 at 3:00 am
A Danbury man has been sentenced to prison for violating the conditions of his supervised release stemming from a federal narcotics conviction involving two fatal drug overdoses. Paul Mignani, 58, ...
- GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom lineon May 1, 2024 at 1:47 am
The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022 ...
- The new drugs preventing allergic reactions to peanuts and other foodson April 30, 2024 at 5:00 pm
But now, finally, there is hope on the horizon, with the arrival of several new therapies that can help people avoid an allergic reaction, not just to food, but other kinds of triggers too.… Offer ...
- With more than 50 overdoses and 8 killed, Texas capital seeing ‘unusually deadly’ string of opioid incidentson April 30, 2024 at 2:14 pm
Although none of the officials would speak about the investigation, they said when outbreaks like this happen, the suspicion is that a "new batch" arrived in town, which is believed to be from the ...
- Texas state capital seeing ‘unusually deadly’ string of suspected overdoses: 'New batch' of drugson April 30, 2024 at 2:14 pm
Emergency personnel in Austin responded to a surge of "unusually deadly" drug overdoses on Tuesday, with more than 30 instances and four fatalities.
- Vermont man sentenced for leading New Hampshire drug trafficking ringon April 30, 2024 at 9:13 am
Atlanta Falcons first-round draft pick Michael Penix Jr. said quarterback Kirk Cousins called him after he was picked No. 8 overall in one of the 2024 NFL Draft's more puzzling selections. Yahoo ...
- New drug candidate reverses obesity in miceon April 30, 2024 at 7:22 am
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' mitochondria. A study published in Nature Metabolism shows that a specific ...
via Bing News